OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
Mark W. Tenforde, Zachary A. Weber, Karthik Natarajan, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 71, Iss. 12, pp. 1637-1646
Open Access | Times Cited: 44
Mark W. Tenforde, Zachary A. Weber, Karthik Natarajan, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 71, Iss. 12, pp. 1637-1646
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023
Ruth Link‐Gelles, Zachary A. Weber, Sarah E. Reese, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 21, pp. 579-588
Open Access | Times Cited: 68
Ruth Link‐Gelles, Zachary A. Weber, Sarah E. Reese, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 21, pp. 579-588
Open Access | Times Cited: 68
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study
Niklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, et al.
BMJ (2023), pp. e075286-e075286
Open Access | Times Cited: 65
Niklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, et al.
BMJ (2023), pp. e075286-e075286
Open Access | Times Cited: 65
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study
Freja Kirsebom, Nick Andrews, Julia Stowe, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. 1235-1243
Open Access | Times Cited: 48
Freja Kirsebom, Nick Andrews, Julia Stowe, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. 1235-1243
Open Access | Times Cited: 48
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 118-118
Open Access | Times Cited: 23
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 118-118
Open Access | Times Cited: 23
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
Leora R. Feldstein, Amadea Britton, Lauren Grant, et al.
JAMA (2024) Vol. 331, Iss. 5, pp. 408-408
Open Access | Times Cited: 14
Leora R. Feldstein, Amadea Britton, Lauren Grant, et al.
JAMA (2024) Vol. 331, Iss. 5, pp. 408-408
Open Access | Times Cited: 14
Timing of elective surgery and risk assessment after SARS‐CoV‐2 infection: 2023 update
Kariem El‐Boghdadly, Tim Cook, Tim Goodacre, et al.
Anaesthesia (2023) Vol. 78, Iss. 9, pp. 1147-1152
Open Access | Times Cited: 24
Kariem El‐Boghdadly, Tim Cook, Tim Goodacre, et al.
Anaesthesia (2023) Vol. 78, Iss. 9, pp. 1147-1152
Open Access | Times Cited: 24
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System
Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
Vaccine (2024) Vol. 42, Iss. 15, pp. 3389-3396
Open Access | Times Cited: 8
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
Vaccine (2024) Vol. 42, Iss. 15, pp. 3389-3396
Open Access | Times Cited: 8
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
Bradley K. Ackerson, Katia Bruxvoort, Lei Qian, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Bradley K. Ackerson, Katia Bruxvoort, Lei Qian, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era
Shanti Pather, Alexander Muik, Ruben Rizzi, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 650-661
Open Access | Times Cited: 16
Shanti Pather, Alexander Muik, Ruben Rizzi, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 650-661
Open Access | Times Cited: 16
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System
Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis
Meng-qun Cheng, Rong Li, Zhiying Weng, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 5
Meng-qun Cheng, Rong Li, Zhiying Weng, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 5
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Morris responds to “Critical analyses concerning COVID-19 vaccines need to be consistently critical, and informed”
Jeffrey S. Morris
American Journal of Epidemiology (2025)
Closed Access
Jeffrey S. Morris
American Journal of Epidemiology (2025)
Closed Access
Preclinical Characterization of the Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14
Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States — September 2022–August 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine
Leah J. McGrath, Deepa Malhotra, Amanda C. Miles, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2342151-e2342151
Open Access | Times Cited: 10
Leah J. McGrath, Deepa Malhotra, Amanda C. Miles, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2342151-e2342151
Open Access | Times Cited: 10
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023
Ruth Link‐Gelles, Zachary A. Weber, Sarah E. Reese, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 7, pp. 1062-1076
Closed Access | Times Cited: 9
Ruth Link‐Gelles, Zachary A. Weber, Sarah E. Reese, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 7, pp. 1062-1076
Closed Access | Times Cited: 9
American Society of Echocardiography COVID-19 Statement Update: Lessons Learned and Preparation for Future Pandemics
James N. Kirkpatrick, Madhav Swaminathan, Adeyinka Adedipe, et al.
Journal of the American Society of Echocardiography (2023) Vol. 36, Iss. 11, pp. 1127-1139
Open Access | Times Cited: 8
James N. Kirkpatrick, Madhav Swaminathan, Adeyinka Adedipe, et al.
Journal of the American Society of Echocardiography (2023) Vol. 36, Iss. 11, pp. 1127-1139
Open Access | Times Cited: 8
Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system
Katia Bruxvoort, Lina S. Sy, Vennis Hong, et al.
Vaccine (2023) Vol. 41, Iss. 49, pp. 7460-7468
Open Access | Times Cited: 8
Katia Bruxvoort, Lina S. Sy, Vennis Hong, et al.
Vaccine (2023) Vol. 41, Iss. 49, pp. 7460-7468
Open Access | Times Cited: 8
Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19
Seong‐Heon Wie, Jaehun Jung, Woo Joo Kim
Journal of Korean Medical Science (2023) Vol. 38, Iss. 44
Open Access | Times Cited: 7
Seong‐Heon Wie, Jaehun Jung, Woo Joo Kim
Journal of Korean Medical Science (2023) Vol. 38, Iss. 44
Open Access | Times Cited: 7
Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults
Nelson Lee, Lena Nguyen, Peter C. Austin, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 5, pp. 1372-1382
Open Access | Times Cited: 7
Nelson Lee, Lena Nguyen, Peter C. Austin, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 5, pp. 1372-1382
Open Access | Times Cited: 7
Correction and Republication: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 11, pp. 292-292
Open Access | Times Cited: 6
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 11, pp. 292-292
Open Access | Times Cited: 6
Effectiveness and durability of a second COVID-19 booster against severe outcomes among older people in Norway: a population-based cohort study comparing mono- and bivalent booster doses
Melanie Stecher, Anja Bråthen Kristoffersen, Kristian Lie, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 6, pp. 1716-1724
Open Access | Times Cited: 6
Melanie Stecher, Anja Bråthen Kristoffersen, Kristian Lie, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 6, pp. 1716-1724
Open Access | Times Cited: 6
COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron
Wilhelmine Meeraus, Anke L. Stuurman, Ilgaz Durukal, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6366-6378
Open Access | Times Cited: 6
Wilhelmine Meeraus, Anke L. Stuurman, Ilgaz Durukal, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6366-6378
Open Access | Times Cited: 6
